ALKBH5 can modulate the Mct4/Slc16a3 expressing state and the TME’s lactate content, as well as the composing parts of tumor-infiltrating regulatory T cells (Tregs) and myeloid-derived suppressor cells. Here, ALKBH5 is linked to neoplasm.